Homegrown private equity firm Kedaara Capital has made a $240 million investment in Axtria, an Agentic AI-first data analytics and cloud software company serving the global life sciences industry, the company announced on Tuesday.
The transaction, structured as a mix of secondary investment and company-sponsored buyback, will provide liquidity to Axtria’s current and former employees.
“At Axtria, we are proud to be building a company that is not only transforming life sciences through data and Agentic AI, but also one that values its people and their contributions through long-term value creation,” said Jaswinder Chadha, President & CEO of Axtria.
Sunish Sharma, Founder and Managing Partner at Kedaara Capital, added, “We are delighted to support Axtria’s talented workforce as they continue to scale as a trusted partner, helping life sciences companies harness the power of technology and Agentic AI.”
Founded in 2010, Axtria provides AI-led solutions across the commercial and clinical spectrum for life sciences organizations worldwide. The company serves 18 of the top 20 global pharmaceutical firms and over 100 companies across more than 75 countries.
